PhRMA
MAY 9, 2023
This week, policymakers on Capitol Hill will continue to discuss the cost of lifesaving medicines and how to make them more affordable for Americans. It’s an important discussion that the biopharmaceutical industry believes we need to have. A new treatment or cure can’t improve a patient’s life if they can’t get it. As the conversation continues in Congress, IQVIA is out with a new and timely report on medicine prices and spending.
Pharmacy Times
MAY 11, 2023
Tackling racial disparities among health care providers can help improve disparities faced by patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MAY 10, 2023
In a highly significant move, a panel of independent experts on Wednesday voted unanimously that the Food and Drug Administration should approve the first over-the-counter birth control bill, a recommendation that holds the potential to transform the way contraception is delivered in the United States. After nearly two days of deliberations, the FDA advisory panel weighed a gamut of data and analyses to assess whether the pill — which was first approved as a prescription medicine decades
Drug Topics
MAY 12, 2023
Sometimes, paid advertising isn’t the best way to get the word out.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PhRMA
MAY 8, 2023
Indiana just joined West Virginia and Arkansas in delivering an important win for Hoosiers who are struggling to afford their medicines. This week, Governor Holcomb signed into law Senate Bill 8 recently passed by the Indiana legislature. This new law will ensure that Indiana patients aren’t paying more for their medicines than their health insurance company or the middlemen known as pharmacy benefit managers (PBMs).
PharmaVoice
MAY 10, 2023
With decades of experience in public health, Boone is leveraging RWE to move the needle within clinical development.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
MAY 12, 2023
Listen to the first episode of RPHCast, where Kevin and Donna educate you on all things statins, blood pressure, cholesterol, and as many curves as you can imagine.
PhRMA
MAY 10, 2023
Today, the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) will examine the cost of insulin and how to make this lifesaving medicine more affordable for patients. The nation’s largest pharmacy benefit managers (PBMs) are expected to testify. These are the middlemen that insurance companies use to determine what’s covered and what patients pay out of pocket at the pharmacy.
PharmaVoice
MAY 8, 2023
The nonprofit generics maker still sees a need for low-cost insulin despite recent moves by major drugmakers to slash the prices of their popular products.
STAT
MAY 8, 2023
“S o, you don’t have it in liquid form?” I asked. The answer, as usual, was no. I hung up the phone and sighed.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MAY 12, 2023
Research shows that patient experiences and sometimes outcomes are improved when they are treated by health care professions from similar communities.
PhRMA
MAY 11, 2023
America is currently facing a mental health crisis — one that is impacting families and individuals in every community, with the COVID-19 pandemic only exacerbating these trends. Mental Health Awareness Month, which is held each year in May, presents an opportunity to discuss ways to address the growing burden of, and stigma surrounding, mental illness.
PharmaVoice
MAY 11, 2023
Whether you’re looking to build a new site or expand lab space, here are the biggest trends impacting life sciences real estate.
Fierce Healthcare
MAY 8, 2023
UnitedHealth extends its hot streak as the most profitable payer in Q1 pminemyer Mon, 05/08/2023 - 13:28
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Topics
MAY 11, 2023
Patients should be screened regardless of age, gender, or time of year.
PhRMA
MAY 8, 2023
Researching and developing new medicines for children is a priority for the biopharmaceutical industry. Despite the scientific complexity and challenges inherent to developing treatments for our youngest patients, there has never been more progress in pediatric health outcomes. The progress we are seeing in pediatric health outcomes is in part due to the advancement in medicines that have been specifically studied in and approved for use in children.
PharmaVoice
MAY 9, 2023
Cutiss CEO Daniela Marino is funneling her bold personality and expertise in regenerative medicine into a startup developing bioengineered skin grafts.
Pharmacy Times
MAY 10, 2023
An FDA committee voted 17-0 to make the once-daily birth control medication Opill available OTC after deciding the benefits outweigh any potential harms.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
MAY 9, 2023
The panelists provide an overview of the treatment model for treating patients with treatment-resistant depression.
STAT
MAY 10, 2023
On the eve of the expiration date for the federally declared coronavirus public health emergency , White House Covid-19 Response Coordinator Ashish Jha warned that the pandemic is far from over. “I don’t see this as an end to the pandemic or fighting Covid,” Jha said at a STAT event in Boston on Wednesday. “I see this as a transition out of this emergency phase into a very different phase.
PharmaVoice
MAY 9, 2023
Antibody-drug conjugates got a major boost with the megamerger of Pfizer and Seagen, and experts believe they will continue to be an important catalyst in biopharma.
Pharmacy Times
MAY 10, 2023
The extra surveillance by a specialty pharmacy teams allows for faster initiation of therapy, earlier recognition of adverse effects, and promotes patient safety.
Drug Topics
MAY 8, 2023
A new CDC report on data collected by the Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder During Pregnancy, indicates that medication for opioid use disorder is more often given to individuals who are White, older, and have private insurance.
Fierce Healthcare
MAY 11, 2023
Industry Voices—Where we go from here: Community pharmacy in a post-pandemic world pminemyer Thu, 05/11/2023 - 14:47
PharmaVoice
MAY 10, 2023
After ushering a blockbuster to market, the chief development officer is channeling her experience into the rare disease space.
Pharmacy Times
MAY 8, 2023
Due to the disease’s chronicity, the variability in treatment response and drug safety profiles, and the availability of multiple therapies, switching or discontinuing treatments is common in psoriasis.
Drug Topics
MAY 8, 2023
Patients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.
Pharmaceutical Technology
MAY 11, 2023
Results published in Nature for a personalised pancreatic cancer vaccine that uses neoantigens from patients’ tumours have lent further support to early positive signals. The vaccine, developed by BioNTech, led to half of the patients with pancreatic cancer in the Phase I trial remaining cancer-free 18 months later. In the study, 16 patients were treated with a vaccine called autogene cevumeran that contained a maximum of 20 neoantigens, alongside Roche’s anti-PD-L1 immunotherapy Tecentriq (atez
PharmaVoice
MAY 8, 2023
Although approvals are off to a slow start in oncology, the agency has been living in the fast lane for neurological disorders and more.
Fierce Healthcare
MAY 10, 2023
PBM, pharma play blame game over drug pricing at hearing pminemyer Wed, 05/10/2023 - 16:10
Drug Topics
MAY 8, 2023
The brand-new treatment from Elanco is currently the only approved therapeutic solution proven to treat canine parvovirus.
Pharmacy Times
MAY 10, 2023
Commonly, essential yet routine and time-consuming tasks, such as answering phone calls, scheduling appointments, or other administrative work, prevent health care workers from focusing on more value-added and enjoyable job functions.
STAT
MAY 8, 2023
EQRx, a company that aimed to lower drug prices by introducing inexpensive me-too medicines, said Tuesday that it has abandoned that plan and is laying off nearly 60% of its workforce. The company’s original business plan was to create new medicines in the same categories as high-priced cancer and specialty drugs and to sell them at lower prices through a “global buyers club” that included insurers and hospitals.
Expert insights. Personalized for you.
279 
Let's personalize your content